Ana L. Silva
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Recombinant vaccine plus anti-parasitic agent in an immunotherapeutic schedules induce partial regression of tegumentary leishmaniasis in a murine model.
Journal: Vaccine
Published: June 03, 2026
In silico discovery and serological validation of Trypanosoma cruzi-specific B-cell epitopes for high-precision Chagas disease diagnosis.
Journal: Frontiers in microbiology
Published: April 14, 2026
Improved detection of paucibacillary and multibacillary leprosy using a novel recombinant chimeric protein.
Journal: Journal of immunological methods
Published: March 20, 2026
Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary study.
Journal: PLoS neglected tropical diseases
Published: February 02, 2026
Diagnostic evaluation of a novel recombinant multi-epitope protein for paucibacillary and multibacillary leprosy.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: November 07, 2025
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis.
Journal: Pathogens (Basel, Switzerland)
Published: September 22, 2025
Recombinant small myristoylated protein-3 and synthetic peptide as diagnostic and prognostic biomarkers for tegumentary leishmaniasis.
Journal: Parasitology international
Published: September 17, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary study.
Journal: Experimental parasitology
Published: February 07, 2025
Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice.
Journal: Frontiers in immunology
Published: December 31, 2024
Urine-based ELISA using a recombinant chimeric protein for the diagnosis of paucibacillary and multibacillary leprosy.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: October 31, 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasis.
Journal: Diagnostic microbiology and infectious disease
Published: October 23, 2024
Showing 1-12 of 12
Last Updated: 09/26/2026